Cargando…

Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography

INTRODUCTION: Double contrast-enhanced ultrasonography (DCUS) is a new method we used in predicting lymph node metastasis (LNM) in patients with early gastric cancer. MATERIAL AND METHODS: Seventy-six patients with early gastric cancer diagnosed by gastroscope and confirmed by pathology after operat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Nianyu, Huang, Pintong, Aronow, Wilbert S., Wang, Zongmin, Nair, Chandra K., Zheng, Zhiqiang, Shen, Xuedong, Yin, Yimei, Huang, Fuguang, Cosgrove, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258739/
https://www.ncbi.nlm.nih.gov/pubmed/22295029
http://dx.doi.org/10.5114/aoms.2011.23412
_version_ 1782221305181896704
author Xue, Nianyu
Huang, Pintong
Aronow, Wilbert S.
Wang, Zongmin
Nair, Chandra K.
Zheng, Zhiqiang
Shen, Xuedong
Yin, Yimei
Huang, Fuguang
Cosgrove, David
author_facet Xue, Nianyu
Huang, Pintong
Aronow, Wilbert S.
Wang, Zongmin
Nair, Chandra K.
Zheng, Zhiqiang
Shen, Xuedong
Yin, Yimei
Huang, Fuguang
Cosgrove, David
author_sort Xue, Nianyu
collection PubMed
description INTRODUCTION: Double contrast-enhanced ultrasonography (DCUS) is a new method we used in predicting lymph node metastasis (LNM) in patients with early gastric cancer. MATERIAL AND METHODS: Seventy-six patients with early gastric cancer diagnosed by gastroscope and confirmed by pathology after operation were examined using DCUS preoperatively. Group N1 included 15 patients with LNM and group N0 61 patients without LNM. RESULTS: In group N1, 13 patients (87%) had marked hyperenhancement during early arterial phase using DCUS, and 2 patients (13%) were unmarked as hyperenhancement. In group N0, 24 patients (39%) had marked hyperenhancement during early arterial phase using DCUS, and 37 patients (61%) had unmarked hyperenhancement. The sensitivity and specificity of marked hyperenhancement in predicting LNM in patients with early gastric cancer was 86.7% and 60.7% respectively, and the Youden’s index was 0.474. The κ value of this method was 0.89. CONCLUSIONS: Double contrast-enhanced ultrasonography is a new valuable method to evaluate LNM at an early stage of gastric cancer and prognosis of early gastric cancer preoperatively.
format Online
Article
Text
id pubmed-3258739
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-32587392012-01-31 Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography Xue, Nianyu Huang, Pintong Aronow, Wilbert S. Wang, Zongmin Nair, Chandra K. Zheng, Zhiqiang Shen, Xuedong Yin, Yimei Huang, Fuguang Cosgrove, David Arch Med Sci Clinical Research INTRODUCTION: Double contrast-enhanced ultrasonography (DCUS) is a new method we used in predicting lymph node metastasis (LNM) in patients with early gastric cancer. MATERIAL AND METHODS: Seventy-six patients with early gastric cancer diagnosed by gastroscope and confirmed by pathology after operation were examined using DCUS preoperatively. Group N1 included 15 patients with LNM and group N0 61 patients without LNM. RESULTS: In group N1, 13 patients (87%) had marked hyperenhancement during early arterial phase using DCUS, and 2 patients (13%) were unmarked as hyperenhancement. In group N0, 24 patients (39%) had marked hyperenhancement during early arterial phase using DCUS, and 37 patients (61%) had unmarked hyperenhancement. The sensitivity and specificity of marked hyperenhancement in predicting LNM in patients with early gastric cancer was 86.7% and 60.7% respectively, and the Youden’s index was 0.474. The κ value of this method was 0.89. CONCLUSIONS: Double contrast-enhanced ultrasonography is a new valuable method to evaluate LNM at an early stage of gastric cancer and prognosis of early gastric cancer preoperatively. Termedia Publishing House 2011-06 2011-07-11 /pmc/articles/PMC3258739/ /pubmed/22295029 http://dx.doi.org/10.5114/aoms.2011.23412 Text en Copyright © 2011 Termedia & Banach http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Xue, Nianyu
Huang, Pintong
Aronow, Wilbert S.
Wang, Zongmin
Nair, Chandra K.
Zheng, Zhiqiang
Shen, Xuedong
Yin, Yimei
Huang, Fuguang
Cosgrove, David
Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography
title Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography
title_full Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography
title_fullStr Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography
title_full_unstemmed Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography
title_short Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography
title_sort predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258739/
https://www.ncbi.nlm.nih.gov/pubmed/22295029
http://dx.doi.org/10.5114/aoms.2011.23412
work_keys_str_mv AT xuenianyu predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT huangpintong predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT aronowwilberts predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT wangzongmin predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT nairchandrak predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT zhengzhiqiang predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT shenxuedong predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT yinyimei predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT huangfuguang predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography
AT cosgrovedavid predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography